(Q41672220)

6 October 2017

1 reference

title

Anxiety, defence and the elevated plus-maze (English)

1 reference

6 October 2017

1 reference

Rodgers RJ

1

1 reference

6 October 2017

Dalvi A

series ordinal

2

1 reference

6 October 2017

language of work or name

1 reference

1 November 1997

1 reference

Neuroscience & Biobehavioral Reviews

6 October 2017

published in

1 reference

6 October 2017

volume

21

1 reference

6 October 2017

issue

6

1 reference

6 October 2017

page(s)

801-810

1 reference

Lasting effects on rodent anxiety of a single exposure to a cat.

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Antipredator defensive behaviors in a visible burrow system.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Twenty-two kHz alarm cries to presentation of a predator, by laboratory rats living in visible burrow systems

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

The characterization and modelling of antipredator defensive behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Chronic handling modifies the anxiolytic effect of diazepam in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against alpha 2-adrenoceptor mediation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

GABAmimetic agents display anxiolytic-like effects in the social interaction and elevated plus maze procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Ethopharmacological analysis of rat behavior on the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Use of the elevated plus maze in the search for novel anxiolytic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Trial 2 in the elevated plus-maze: a different form of fear?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Stretched attend posture, a non-social form of ambivalence, is sensitive to a conflict-reducing drug action.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Effects of benzodiazepine receptor antagonist, flumazenil, on antinociceptive and behavioural responses to the elevated plus-maze in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

The use of a plus-maze to measure anxiety in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Ethologically-based animal models of anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

The relation between fear induced by novel stimulation and exploratory drive

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Rat (Rattus norvegicus) defensive behavior in total darkness: risk-assessment function of defensive burying.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Effects of BOC-CCK-4 and L 365.260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus maze

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

A step in the right direction: comment on '5-HT and mechanisms of defence'

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Anxiety enhancement in the murine elevated plus maze by immediate prior exposure to social stressors.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Anxiolytic-like effect of (S)-WAY 100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Antianxiety and behavioral suppressant actions of the novel 5-HT1A receptor agonist, flesinoxan

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Profile of action of 5-HT3 receptor antagonists, ondansetron and WAY 100289, in the elevated plus-maze test of anxiety of mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Effects of ritanserin and 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the murine elevated plus-maze test of anxiety: an ethopharmacological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Benzodiazepines and their antagonists: a pharmacoethological analysis with particular reference to effects on "aggression".

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Relationships between exploratory behaviour and fear: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

GABA and the behavioral effects of anxiolytic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Neurotransmitters, anxiety and benzodiazepines: a behavioral review

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Animal models for the study of anti-anxiety agents: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Anxiogenic stimuli in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

Differences in fear motivated behaviors among inbred mouse strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900058-9

7 January 2021

10.1016/S0149-7634(96)00058-9

Identifiers

DOI

1 reference

6 October 2017

1 reference